![Gunnar Olof Olsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gunnar Olof Olsson
Directeur/Membre du Conseil chez
CERENO SCIENTIFIC AB
Fortune : 2 894 $ au 31/05/2026
Profil
Gunnar Olof Olsson is Vice Chairman at Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt, Chairman at Betagenon Sweden AB since 2021, Chairman at Betagenon Bio AB, Vice Chairman at the University of Lund, Director at BioCrine AB, Director at IRLAB Therapeutics AB since 2017, Director at Gesynta Pharma AB, Director at Olsson Solutions AB, Director at Amplifier TX AB, Independent Director at Cereno Scientific AB since 2024, and Principal at Olsson Solutions Kommanditbolag.
Former roles include Chairman at Athera Biotechnologies AB, Director at The European Society of Cardiology, and Manager-Global Cardiovascular at AstraZeneca AB. Education includes a doctorate from Karolinska Institutet and undergraduate studies at the International Institute for Management Development.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2024 | 5 000 ( 0 % ) | 2 894 $ | 31/05/2026 |
Postes actifs de Gunnar Olof Olsson
| Sociétés | Poste | Début |
|---|---|---|
| CERENO SCIENTIFIC AB | Directeur/Membre du Conseil | 01/01/2024 |
| IRLAB THERAPEUTICS AB | Directeur/Membre du Conseil | 20/02/2023 |
BioCrine AB | Directeur/Membre du Conseil | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Directeur/Membre du Conseil | - |
Olsson Solutions AB | Directeur/Membre du Conseil | - |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Operates as a heart and lung foundation | Directeur/Membre du Conseil | - |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases | Président | 27/05/2021 |
Betagenon Bio AB | Président | - |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Directeur/Membre du Conseil | - |
Anciens postes connus de Gunnar Olof Olsson
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Formation de Gunnar Olof Olsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioCrine AB | |
The European Society of Cardiology | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Operates as a heart and lung foundation | Commercial Services |
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases | Health Technology |
Cereno Scientific AB
 Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
IRLAB Therapeutics AB
 IRLAB Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for neurological diseases | Health Technology |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Health Technology |
Olsson Solutions AB | |
Betagenon Bio AB | |
Amplifier TX AB
Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Health Technology |
